NMAHP Research Unit, University of Stirling, Stirling, UK.
Institute of Social Marketing, University of Stirling, Stirling, UK.
Cochrane Database Syst Rev. 2023 Oct 5;10(10):CD014873. doi: 10.1002/14651858.CD014873.pub2.
Chronic non-cancer pain in childhood is widespread, affecting 20% to 35% of children and young people worldwide. For a sizeable number of children, chronic non-cancer pain has considerable negative impacts on their lives and quality of life, and leads to increased use of healthcare services and medication. In many countries, there are few services for managing children's chronic non-cancer pain, with many services being inadequate. Fourteen Cochrane Reviews assessing the effects of pharmacological, psychological, psychosocial, dietary or physical activity interventions for managing children's chronic non-cancer pain identified a lack of high-quality evidence to inform pain management. To design and deliver services and interventions that meet the needs of patients and their families, we need to understand how children with chronic non-cancer pain and their families experience pain, their views of services and treatments for chronic pain, and which outcomes are important to them.
Review strategy: we comprehensively searched 12 bibliographic databases including MEDLINE, CINAHL, PsycInfo and grey literature sources, and conducted supplementary searches in 2020. We updated the database searches in September 2022.
To identify published and unpublished qualitative research with children aged 3 months to 18 years with chronic non-cancer pain and their families focusing on their perceptions, experiences and views of chronic pain, services and treatments. The final inclusion criteria were agreed with a patient and public involvement group of children and young people with chronic non-cancer pain and their families.
We conducted a qualitative evidence synthesis using meta-ethnography, a seven-phase, systematic, interpretive, inductive methodology that takes into account the contexts and meanings of the original studies. We assessed the richness of eligible studies and purposively sampled rich studies ensuring they addressed the review questions. Cochrane Qualitative Methods Implementation Group guidance guided sampling. We assessed the methodological limitations of studies using the Critical Appraisal Skills Programme tool. We extracted data on study aims, focus, characteristics and conceptual findings from study reports using NVivo software. We compared these study data to determine how the studies related to one another and grouped studies by pain conditions for synthesis. We used meta-ethnography to synthesise each group of studies separately before synthesising them all together. Analysis and interpretation of studies involved children with chronic non-cancer pain and their families and has resulted in theory to inform service design and delivery. Sampling, organising studies for synthesis, and analysis and interpretation involved our patient and public involvement group who contributed throughout the conduct of the review. We used the GRADE-CERQual (Confidence in the Evidence from Reviews of Qualitative research) approach to assess our confidence in each review finding. We used a matrix approach to integrate our findings with existing Cochrane Reviews on treatment effectiveness for children's chronic non-cancer pain.
We synthesised 43 studies sampled from 170 eligible studies reported in 182 publications. Included studies involved 633 participants. GRADE-CERQual assessments of findings were mostly high (n = 21, 58%) or moderate (n = 12, 33%) confidence with three (8%) low or very low confidence. Poorly managed, moderate or severe chronic non-cancer pain had profound adverse impacts on family dynamics and relationships; family members' emotions, well-being, autonomy and sense of self-identity; parenting strategies; friendships and socialising; children's education and future employment prospects; and parental employment. Most children and parents understood chronic non-cancer pain as having an underlying biological cause and wanted curative treatment. However, families had difficulties seeking and obtaining support from health services to manage their child's pain and its impacts. Children and parents felt that healthcare professionals did not always listen to their experiences and expertise, or believe the child's pain. Some families repeatedly visited health services seeking a diagnosis and cure. Over time, some children and families gave up hope of effective treatment. Outcomes measured within trials and Cochrane Reviews of intervention effects did not include some outcomes of importance to children and families, including impacts of pain on the whole family and absence of pain. Cochrane Reviews have mainly neglected a holistic biopsychosocial approach, which specifies the interrelatedness of biological, psychological and social aspects of illness, when selecting outcome measures and considering how chronic pain management interventions work.
AUTHORS' CONCLUSIONS: We had high or moderate confidence in the evidence contributing to most review findings. Further research, especially into families' experiences of treatments and services, could strengthen the evidence for low or very low confidence findings. Future research should also explore families' experiences in low- to middle-income contexts; of pain treatments including opioid use in children, which remains controversial; and of social care services. We need development and testing of family-centred interventions and services acceptable to families. Future trials of children's chronic non-cancer pain interventions should include family-centred outcomes.
儿童慢性非癌痛在全球范围内普遍存在,影响着 20%至 35%的儿童和青少年。对于相当数量的儿童来说,慢性非癌痛对他们的生活和生活质量产生了相当大的负面影响,并导致更多地使用医疗保健服务和药物。在许多国家,管理儿童慢性非癌痛的服务很少,许多服务都不充分。十四项评估药物治疗、心理、心理社会、饮食或体育活动干预措施管理儿童慢性非癌痛效果的 Cochrane 综述发现,缺乏高质量证据来指导疼痛管理。为了设计和提供满足患者及其家属需求的服务和干预措施,我们需要了解患有慢性非癌痛的儿童及其家属对慢性非癌痛、治疗和服务的体验和看法,以及他们认为哪些结果对他们重要。
综述策略:我们全面检索了 12 个文献数据库,包括 MEDLINE、CINAHL、PsycInfo 和灰色文献来源,并在 2020 年进行了补充检索。我们于 2022 年 9 月更新了数据库检索。
为了确定研究对象是患有慢性非癌痛的 3 个月至 18 岁的儿童及其家属,重点关注他们对慢性疼痛、服务和治疗的看法、经历和看法。最终的纳入标准是与儿童和青少年慢性非癌痛患者及其家属的患者和公众参与小组达成一致的。
我们使用元人种学进行了定性证据综合,这是一种七阶段、系统、解释性、归纳性方法,考虑了原始研究的背景和意义。我们评估了合格研究的丰富性,并有意选择丰富的研究,确保它们解决了综述问题。Cochrane 定性方法实施小组指南指导抽样。我们使用关键评估技能计划工具评估研究的方法局限性。我们使用 NVivo 软件从研究报告中提取关于研究目的、重点、特征和概念发现的研究数据。我们将这些研究数据进行比较,以确定研究之间的相互关系,并根据疼痛状况对研究进行分组进行综合。我们使用元人种学分别对每组研究进行综合,然后将它们全部综合在一起。研究的分析和解释涉及患有慢性非癌痛的儿童及其家属,并导致了为服务设计和提供提供信息的理论。抽样、为综合组织研究以及分析和解释涉及我们的患者和公众参与小组,他们在整个审查过程中提供了帮助。我们使用 GRADE-CERQual(从定性研究评估证据的信心)方法评估我们对每个综述结果的信心。我们使用矩阵方法将我们的发现与儿童慢性非癌痛治疗的现有 Cochrane 综述结果相结合。
我们综合了 43 项研究,这些研究是从 170 项符合条件的研究中选取的,涉及 633 名参与者。包括的研究中,GRADE-CERQual 评估结果大多为高(n=21,58%)或中(n=12,33%)置信度,有三个(8%)为低或极低置信度。管理不善、中度或重度慢性非癌痛对家庭动态和关系产生了深远的负面影响;家庭成员的情绪、幸福感、自主权和自我认同感;育儿策略;友谊和社交;儿童的教育和未来就业前景;以及父母的就业。大多数儿童和家长都认为慢性非癌痛有潜在的生物学原因,并希望进行治疗。然而,家庭在寻求和获得支持以管理孩子的疼痛及其影响方面遇到了困难。儿童和家长认为医疗保健专业人员并不总是倾听他们的经历和专业知识,也不相信孩子的疼痛。一些家庭反复到卫生服务机构寻求诊断和治疗。随着时间的推移,一些儿童和家庭放弃了有效的治疗希望。试验和儿童慢性非癌痛干预措施 Cochrane 综述中没有包括一些对儿童和家庭重要的结果,包括疼痛对整个家庭的影响和没有疼痛。Cochrane 综述主要忽视了一种整体的生物心理社会方法,该方法指定了疾病的生物学、心理和社会方面的相互关系,当选择结局测量和考虑慢性疼痛管理干预措施如何发挥作用时。
我们对大多数综述结果的证据有高或中置信度。进一步的研究,特别是关于家庭对治疗和服务的经验,可以加强对低或极低置信度结果的证据。未来的研究还应探讨中低收入背景下的家庭经验;包括儿童在内的疼痛治疗方法,包括阿片类药物的使用,这仍然存在争议;以及社会保健服务。我们需要开发和测试以家庭为中心的干预措施和服务,这些措施和服务是家庭可以接受的。未来针对儿童慢性非癌痛干预措施的试验应包括以家庭为中心的结局。